Stock listing
CVRX Stock Price, News, Filings & Events — Cvrx, Inc.
Selected listing: CVRX · NASDAQ · USD · US
This page tracks Cvrx, Inc.'s CVRX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CVRX:NASDAQ. CVRX:NASDAQ is the stock-level entry point for investors researching Cvrx, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cvrx, Inc. is a public company traded under the ticker CVRX in the American market. The company has a market capitalization of approximately $130.3 million. Cvrx focuses on developing innovative medical technologies to improve patient outcomes.
- Ticker
- CVRX:NASDAQ
- Asset type
- Stock
- Market cap
- $82.1M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD
Cvrx, Inc. CVRX:NASDAQ stock context
This page tracks Cvrx, Inc.'s CVRX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CVRX:NASDAQ. CVRX:NASDAQ is the stock-level entry point for investors researching Cvrx, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cvrx, Inc. is a public company traded under the ticker CVRX in the American market. The company has a market capitalization of approximately $130.3 million. Cvrx focuses on developing innovative medical technologies to improve patient outcomes.
Latest news from Cvrx, Inc.
CVRx Responds to Letter from Pointillist Family Office
August 25, 2026
CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy
August 24, 2026
Jorey Chernett, Owner of More than 5.5% of Outstanding Shares of CVRx, Calls on Board to Begin Immediate Process to Pursue Sale of the Co...
August 24, 2026
CVRx Announces Sales Leadership Transition
August 11, 2026
CVRx to Present at Canaccord Genuity's 46th Annual Growth Conference
July 28, 2026
Research Cvrx, Inc.
Cvrx, Inc. investor report
Review AI stock analysis and investor report context for CVRX:NASDAQ.
Cvrx, Inc. company profile
View the public company page for Cvrx, Inc. on 6ix.
Cvrx, Inc. news
Read company news and market updates connected to Cvrx, Inc..
Cvrx, Inc. investor events
Find investor webinars, events, and replay context for Cvrx, Inc..